phospho p38 thr180 thr182 d3f9 rabbit monoclonal (Cell Signaling Technology Inc)

Structured Review
![DHA accelerates caspase-1 protein synthesis in a p38MAP-dependent manner (A) Protein synthesis signaling diagram. Inhibitors for signaling components are denoted in red. (B) ES2 and SK-OV3 cells were treated with DHA at IC50 for 16 or 24 h, followed by western blotting to detect <t>phosphor-p38MAPK,</t> p38MAPK, phosphor-Akt, Akt, phosphor-Mnk1, Mnk1, phosphor-Erk, Erk, phosphor-eIF4E, and eIF4E with the respective antibodies. (C) ES2 cells were treated with DHA in the absence or presence of AZD5383, Trametinib, BIRB796, or Rapamycin for 24 h, followed by western blotting to detect caspase-1 and GAPDH with the respective antibodies. (D) ES2 and SK-OV3 cells were cultured in a methionine-free medium for 2 h, and then fed with a medium containing AHA in the absence or presence of BIRB796 for 16 h. Cells were lysed and AHA-incorporated proteins were isolated for western blotting to detect caspase-1 with caspase-1 antibody. Cell lysates before isolating AHA-incorporated proteins were also subjected to western blotting to detect GAPDH to ensure equal loading. (E) ES2, SK-OV3, and OCC1 cells were treated with vehicle or 100 μM DHA in the absence or presence of AZD5363, Trametinib, Rapamycin, BIRB796, or 796 CPG57380 for 24 h followed by MTT assay to analyze cell viability. % of cell viability was calculated as [(Control – Treatment)/Control] x 100. Control: vehicle-treated; Treatment: DHA or DHA + inhibitors. Data are means ± SEM. ∗∗∗, p < 0.001.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6124/pmc10696124/pmc10696124__gr8.jpg)
Phospho P38 Thr180 Thr182 D3f9 Rabbit Monoclonal, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho p38 thr180 thr182 d3f9 rabbit monoclonal/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "ASC/inflammasome-independent pyroptosis in ovarian cancer cells through translational augmentation of caspase-1"
Article Title: ASC/inflammasome-independent pyroptosis in ovarian cancer cells through translational augmentation of caspase-1
Journal: iScience
doi: 10.1016/j.isci.2023.108408
![... 24 h, followed by western blotting to detect phosphor-p38MAPK, p38MAPK, phosphor-Akt, Akt, phosphor-Mnk1, Mnk1, phosphor-Erk, Erk, phosphor-eIF4E, ... DHA accelerates caspase-1 protein synthesis in a p38MAP-dependent manner (A) Protein synthesis signaling diagram. Inhibitors for signaling components are denoted in red. (B) ES2 and SK-OV3 cells were treated with DHA at IC50 for 16 or 24 h, followed by western blotting to detect phosphor-p38MAPK, p38MAPK, phosphor-Akt, Akt, phosphor-Mnk1, Mnk1, phosphor-Erk, Erk, phosphor-eIF4E, and eIF4E with the respective antibodies. (C) ES2 cells were treated with DHA in the absence or presence of AZD5383, Trametinib, BIRB796, or Rapamycin for 24 h, followed by western blotting to detect caspase-1 and GAPDH with the respective antibodies. (D) ES2 and SK-OV3 cells were cultured in a methionine-free medium for 2 h, and then fed with a medium containing AHA in the absence or presence of BIRB796 for 16 h. Cells were lysed and AHA-incorporated proteins were isolated for western blotting to detect caspase-1 with caspase-1 antibody. Cell lysates before isolating AHA-incorporated proteins were also subjected to western blotting to detect GAPDH to ensure equal loading. (E) ES2, SK-OV3, and OCC1 cells were treated with vehicle or 100 μM DHA in the absence or presence of AZD5363, Trametinib, Rapamycin, BIRB796, or 796 CPG57380 for 24 h followed by MTT assay to analyze cell viability. % of cell viability was calculated as [(Control – Treatment)/Control] x 100. Control: vehicle-treated; Treatment: DHA or DHA + inhibitors. Data are means ± SEM. ∗∗∗, p < 0.001.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6124/pmc10696124/pmc10696124__gr8.jpg)
Figure Legend Snippet: DHA accelerates caspase-1 protein synthesis in a p38MAP-dependent manner (A) Protein synthesis signaling diagram. Inhibitors for signaling components are denoted in red. (B) ES2 and SK-OV3 cells were treated with DHA at IC50 for 16 or 24 h, followed by western blotting to detect phosphor-p38MAPK, p38MAPK, phosphor-Akt, Akt, phosphor-Mnk1, Mnk1, phosphor-Erk, Erk, phosphor-eIF4E, and eIF4E with the respective antibodies. (C) ES2 cells were treated with DHA in the absence or presence of AZD5383, Trametinib, BIRB796, or Rapamycin for 24 h, followed by western blotting to detect caspase-1 and GAPDH with the respective antibodies. (D) ES2 and SK-OV3 cells were cultured in a methionine-free medium for 2 h, and then fed with a medium containing AHA in the absence or presence of BIRB796 for 16 h. Cells were lysed and AHA-incorporated proteins were isolated for western blotting to detect caspase-1 with caspase-1 antibody. Cell lysates before isolating AHA-incorporated proteins were also subjected to western blotting to detect GAPDH to ensure equal loading. (E) ES2, SK-OV3, and OCC1 cells were treated with vehicle or 100 μM DHA in the absence or presence of AZD5363, Trametinib, Rapamycin, BIRB796, or 796 CPG57380 for 24 h followed by MTT assay to analyze cell viability. % of cell viability was calculated as [(Control – Treatment)/Control] x 100. Control: vehicle-treated; Treatment: DHA or DHA + inhibitors. Data are means ± SEM. ∗∗∗, p < 0.001.
Techniques Used: Western Blot, Cell Culture, Isolation, MTT Assay

Figure Legend Snippet:
Techniques Used: Recombinant, Protease Inhibitor, Pore Size, Western Blot, Bicinchoninic Acid Protein Assay, Flow Cytometry, Colorimetric Assay, Enzyme-linked Immunosorbent Assay, LDH Cytotoxicity Assay, Software